These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3923706)

  • 1. Ia+ dendritic cells lining the dermo-epidermal junction in bullous skin disorders, associated with the deposition of immune complexes.
    Drijkoningen M; de Wolf-Peeters C; van den Oord JJ; Vanneste A; Degreef H; Desmet V
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(3):301-7. PubMed ID: 3923706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoelectron microscopic investigation of HLA-DR-positive dendritic cells at the dermo-epidermal junction in skin disorders associated with the deposition of immune complexes.
    Drijkoningen M; De Vos R; De Wolf-Peeters C; Degreef H; Desmet V
    Ultrastruct Pathol; 1986; 10(2):123-8. PubMed ID: 3515706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [OKIa+ cells lining the dermo-epidermal junction in bullous pemphigoid].
    Morita H; Kuramoto M; Yu M; Yamagata M; Endo H; Sagami S
    Nihon Hifuka Gakkai Zasshi; 1987 Jun; 97(7):833-5. PubMed ID: 3312726
    [No Abstract]   [Full Text] [Related]  

  • 4. Linear dermo-epidermal IgA deposition in bullous pemphigoid.
    van Joost T; Faber WR; Westerhof W; de Mari F
    Acta Derm Venereol; 1979; 59(5):463-5. PubMed ID: 93374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
    J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of the membrane attack complex of complement in bullous pemphigoid.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-presenting cells in the skin and placenta in pemphigoid gestationis.
    Kelly SE; Black MM; Fleming S
    Br J Dermatol; 1990 May; 122(5):593-9. PubMed ID: 2191709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural localization of immunoglobulins in the dermo-epidermal junction of patient with bullous pemphigoid.
    Masutani M; Ogawa H; Taneda A; Shoji M; Miyazaki H
    J Dermatol; 1978 Jun; 5(3):107-12. PubMed ID: 353111
    [No Abstract]   [Full Text] [Related]  

  • 10. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel antigen of the dermal-epidermal junction defined by an anti-CD1b monoclonal antibody (NU-T2).
    Kanitakis J; Zambruno G; Wang YZ; Roche P; Berti E; Schmitt D
    Arch Dermatol Res; 1993; 285(6):313-21. PubMed ID: 8215581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of monoclonal antibodies in skin basement membrane research.
    Fine JD
    Coll Relat Res; 1984 Jan; 4(1):75-81. PubMed ID: 6373116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic non-hereditary dermo-epidermal bullous dermatoses in the child. Immunopathologic and case review].
    Fabbri P; Di Blasi A; Battini ML
    G Ital Dermatol Venereol; 1988 Apr; 123(4):147-50. PubMed ID: 3053430
    [No Abstract]   [Full Text] [Related]  

  • 15. Light Chain Deposition Disease with Bullous Skin Lesions Mimicking Atypical Bullous Pemphigoid.
    Malphettes M; Bonnet P; Schneider P; Vignon M; Baron M; Bouaziz JD; Battistella M
    Acta Derm Venereol; 2018 Jan; 98(1):140-141. PubMed ID: 29135016
    [No Abstract]   [Full Text] [Related]  

  • 16. Human epidermal Langerhans' cells in bullous pemphigoid.
    Emtestam L; Hovmark A; Lindberg M; Asbrink E
    Acta Derm Venereol; 1987; 67(6):529-32. PubMed ID: 2451382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex-mediated complement activation in bullous pemphigoid.
    Gammon WR
    Clin Dermatol; 1987; 5(1):110-6. PubMed ID: 3552180
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible role of Hsp70 in autoantigen shuttling to the dermo-epidermal junction in systemic lupus erythematosus.
    Villalobos-Hurtado R; Sánchez-Rogriguez SH; Avalos-Díaz E; Herrera-Esparza R
    Reumatismo; 2003; 55(3):155-8. PubMed ID: 14513114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes gestationis with transient bullous lesions in the newborn.
    Bonifazi E; Meneghini CL
    Pediatr Dermatol; 1984 Jan; 1(3):215-8. PubMed ID: 6387666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
    Gao SQ; Bystryn JC
    J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.